bdn821

XXII make or break time

AMEX:XXII   None
Really like this stock but short term isn’t looking so good. The FDA approval will be the catalyst but if we can regain that POC I will feel a bit more comfortable
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。